Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mood-stabilizing drugs in depression.

R C Shelton1

  • 1Department of Psychiatry, Vanderbilt University, Nashville, Tenn, USA. RICHARD.SHELTON@MCMAIL.VANDERBILT.EDU

The Journal of Clinical Psychiatry
|April 7, 1999
PubMed
Summary

Mood-stabilizing drugs like lithium and antipsychotics effectively treat bipolar disorder mania and depression. They also help prevent relapse and manage difficult-to-treat refractory depression cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular analyses of circadian gene variants reveal sex-dependent links between depression and clocks.

Translational psychiatry·2016
Same author

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Acta psychiatrica Scandinavica·2015
Same author

Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.

Translational psychiatry·2015
Same author

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.

Molecular psychiatry·2011
Same author

Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression.

Molecular psychiatry·2010
Same author

Can pharmacotherapists be too supportive? A process study of active medication and placebo in the treatment of depression.

Psychological medicine·2009

Area of Science:

  • Psychiatry and Pharmacology

Background:

  • Mood-stabilizing drugs are primary treatments for bipolar disorder, particularly mania.
  • Evidence suggests efficacy in depressive episodes for both bipolar and unipolar depression.

Purpose of the Study:

  • To review the multifaceted effects of mood stabilizers in bipolar and unipolar depression.
  • To cover acute treatment, relapse prevention, and refractory case management.

Main Methods:

  • Literature review of mood-stabilizing agents.
  • Focus on lithium, anticonvulsants, and antipsychotics.
  • Inclusion of atypical antipsychotics and emerging research.

Main Results:

  • Mood stabilizers demonstrate effectiveness in acute depressive phases.
  • These agents aid in preventing relapse and recurrence of mood episodes.
  • Lithium is a key augmentation strategy for treatment-resistant depression.

Conclusions:

  • Mood stabilizers offer broad utility beyond mania, encompassing depressive states.
  • Antipsychotics, especially atypicals, warrant further investigation for mood disorders.
  • Continued research is crucial for optimizing mood stabilizer use.

Related Experiment Videos